Through this collaboration, Onsite Women’sHealth will offer MammoScreen across its 150+ locations to elevate patient care, while empowering radiologists with AI-driven insights to support earlier and more accurate cancer detection.

“These improvements underscore our dedication to supporting physicians in making informed decisions that improve patient outcomes. We believe the new features of HeartSee will set a new standard in cardiac care, helping to detect and treat coronary artery disease more effectively and efficiently than ever before,” said Derek Steptoe, Senior Manager of Nuclear Cardiology, Bracco.

SubtleHD sets a new benchmark in image quality and speed for European MRI providers.

This partnership immediately positions NeuralCure AI for rapid, real-world application, further solidifying its role as a pioneer in AI-powered healthcare solutions. Unlike traditional AI models that provide generalized insights, NeuralCure AI creates patient-specific digital twins and runs constant treatment simulations, helping physicians make more informed, data-driven decisions without replacing clinical judgment.